Article Details
Retrieved on: 2021-02-15 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
It is also approved to treat primary immunodeficiency (PI) in patients two years of age. In the past year, Pfizer's stock has risen 4.5% compared with an ...
Article found on: www.zacks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here